CFDE Data Portal | Search PRLHR

	Label	Description
	PRLHR associations Collection (Entity type)	Associations for PRLHR_associations
	PRLHR associations.tsv File (Entity type)	A file from IDG as part of the Harmonizome project
	PRLHR Gene (Entity type)	ENSG00000119973 - prolactin releasing hormone receptor
	GSE100148 EZH2 inhibition 10 v 5 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE155031 catechin SH-SY5Y 5 v 3 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE225901 dexamethasone 2 v 3 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE103510 STAT5 inhibition 2 v 0 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE56010 adenosine 4 v 1 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE119978,GSE180930 2 V 7 CISPLATIN HUMAN DN Gene Set (Entity type)	A Gene Set from LINCS
	GSE225901 dexamethasone 2 v 1 human dn Gene Set (Entity type)	A Gene Set from LINCS

PRLHR associations

Associations for PRLHR_associations

PRLHR associations.tsv

A file from IDG as part of the Harmonizome project

PRLHR

ENSG00000119973 - prolactin releasing hormone receptor

GSE100148 EZH2 inhibition 10 v 5 human dn

A Gene Set from LINCS

GSE155031 catechin SH-SY5Y 5 v 3 human up

A Gene Set from LINCS

GSE225901 dexamethasone 2 v 3 human dn

A Gene Set from LINCS

GSE103510 STAT5 inhibition 2 v 0 human dn

A Gene Set from LINCS

GSE56010 adenosine 4 v 1 human dn

A Gene Set from LINCS

GSE119978,GSE180930 2 V 7 CISPLATIN HUMAN DN

A Gene Set from LINCS

GSE225901 dexamethasone 2 v 1 human dn

A Gene Set from LINCS

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.